Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Time For Independent FDA? COVID-19 Political Pressure Reignites Debate

Oct 09 2020

• By Kate Rawson

FDABldg1ExteriorWithCircle_1200x675 — Will there be renewed momentum to make the FDA independent of HHS as a result of the pandemic? • Source: File photo

Related Content

Transparency, And A Mirror: US FDA Advice On COVID-19 Vaccine EUAs Finally Published – Twice

Oct 07 2020

COVID-19 Vaccines: BIO Pushes For EUA Guidance, While HHS’ Azar Downplays Its Importance

Oct 03 2020

Coronavirus Update: As Trump Leaves Hospital, White House Blocks FDA Vaccines Guidance

Oct 06 2020

An Independent FDA: An Idea Whose Time Is Still Coming

Jun 27 2016

Related Companies

Sarepta Therapeutics, Inc.

Additional Topics

United States FDA Coronavirus COVID-19 Policy BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window